Evommune, Inc. share price logo

Evommune, Inc.

NYSE: EVMN

$8.63

+0.79

(+10.08%)

Live

as on

Evommune, Inc. Stock Performance

as on November 12, 2026 at 7:54 am IST

  • Day's Low

    Day's High

    $7.75
    $8.93
    downward going graph

    10.20%

    Downside

    3.48%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Evommune, Inc. share price movements today

Previous Close
$7.84
Open
$7.90
Volume
1.6M
Market Cap
$241.3M
Day's Low - High
$7.75 - $8.93

Evommune, Inc. Historical Returns

1 Month Return
+ 25.44 %
3 Month Return
-44.83 %
1 Year Return
-59.73 %
3 Year Return
0 %
5 Year Return
0 %

Evommune, Inc. Stock Fundamentals & Key Indicators

Check Evommune, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$241.3M

EPS (TTM)

-3.37

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.33

Industry PE ratio

-3.10

PEG Ratio

0.06

EBITDA

-100.4M

Revenue (TTM)

10.0M

Profit Margin

100.00%

Return On Equity TTM

-62.63%

Evommune, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evommune, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$241.3MNA-2.33100.00%0.00%
Neutral$101.5B11.08%-35.4828.00%0.00%
StrongBuy$46.5BNA68.2588.39%0.00%
StrongBuy$138.7B194.77%34.9985.57%0.00%
Buy$93.5B46.19%19.5185.77%0.41%

Stock Returns calculator for Evommune, Inc. Stock including INR - Dollar returns

The Evommune, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Evommune, Inc. investment value today

Current value as on today

₹46,937

Returns

-₹53,063

(-53.06%)

Returns from Evommune, Inc. Stock

-₹55,675 (-55.68%)

Dollar Impact

₹2,612 (+2.61%)

Analyst Recommendation on Evommune, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evommune, Inc.. Average target price of $23.6666666666667

Evommune, Inc. Share Price Target

Get share price movements and forecasts by analysts on Evommune, Inc..

Current Price

$8.63

Analyzed by

8 Analysts

High

$30

0

Low

$18

Evommune, Inc. target price $0, a slight upside of 0% compared to current price of $8.63. According to 8 analysts rating.

Indian Investors' Interest in Evommune, Inc. Stock

Search interest for Evommune, Inc. Stock has increased by 159% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:159% versus previous 30 day period

Evommune, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
3
-
10
-
-
-
Gross Profit
-
-
2
0
10
-
-
-
Operating Income
-16
-18
-15
-22
-13
-29
-23
-34
EBITDA
-16
-17
-14
-13
-13
-29
-23
-34
Interest Expense
-
-
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-15
-18
-14
-13
-12
-28
-21
-32
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-15
-18
-14
-13
-12
-28
-21
-32
Net Profit Margin
0.00%
0.00%
87.43%
0.00%
100.00%
0.00%
0.00%
0.00%

Evommune, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
7
13
Gross Profit
4
5
13
Operating Income
-37
-70
-81
EBITDA
-32
-65
-79
Interest Expense
0
0
-
Depreciation
1
1
1
Income Before Tax
-34
-66
-68
Income Tax Expense
-
-
-
Net Income
-34
-66
-68
Net Profit Margin
80.00%
81.61%
100.00%

Evommune, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-15
-20
-14
-13
-12
-28
-21
-32
Operating Cash Flow
-26
-18
-23
-26
-9
-16
-27
-20
Investing Cash Flow
9
-33
13
18
-23
-122
-85
31
Financing Cash Flow
0
49
0
64
0
156
117
0
Change in Cash
-16
-1
5
56
-33
17
4
11

Evommune, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-34
-66
-68
Operating Cash Flow
-29
-58
-76
Investing Cash Flow
-48
-3
-115
Financing Cash Flow
63
49
220
Change in Cash
29
-12
29

Global Institutional Holdings in Evommune, Inc.

Check out the Institutions with significant holdings in Evommune, Inc..

Funds
Holdings
LSP 7 Cooperative UA
14.57%
Felice Isabel Verduyn-van Weegen
14.57%
Ra Capital Management, Llc
9.63%
Peter Kolchinsky
9.63%
Robert Lorne Hopfner
9.29%

Evommune, Inc. News & Key Events

  • img

    Today's Timeline - 04 November

    Thu, 05:00 AM

    -

    Evommune expands autoimmune pipeline through licensing EVO570 and announces $30M private placement for clinical development.

Insights on Evommune, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EVMN stock has moved up by 29.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 849.8% return, outperforming this stock by 909.5%

About Evommune, Inc.

Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
OrganisationEvommune, Inc.
Headquarters1841 Page Mill Road, Palo Alto, CA, 94304, US
IndustryBiotechnology
CEOLuis C. Pena

Key Management of Evommune, Inc.

Name

Title

Mr. Luis C. Pena

Founder, President, CEO & Director

Mr. Kyle Carver CPA, M.B.A.

Chief Financial Officer

Dr. Eugene Andrew Bauer M.D.

Co-Founder, Chief Medical Officer & Director

Dr. Jeegar Patel Ph.D.

Chief Scientific Officer

Dr. Lou Sehl Ph.D.

Senior Vice President of Technical Operations

Mr. Gregory S. Moss Esq.

Chief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer

Ms. Janice Drew M.P.H.

Chief of Development Operations

Dr. Daniel J. Burge M.d.

Senior Vice President of Clinical Development

Mr. J. Mark Jackson M.D.

Senior Vice President of Clinical Development

FAQs

What is Evommune, Inc. share price today?

Evommune, Inc. share price today is $8.63 as on . Evommune, Inc. share today touched a day high of $8.93 and a low of $7.75.

What is the 52 week high and 52 week low for Evommune, Inc. share?

Evommune, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Evommune, Inc. stock price today i.e. is trending at $8.63,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Evommune, Inc.'s market capitalisation today?

Evommune, Inc. market capitalisation is $0.00T as on .

How to invest in Evommune, Inc. Stock (EVMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evommune, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Evommune, Inc. Stock (EVMN) from India?

Indian investors can start investing in Evommune, Inc. (EVMN) shares with as little as ₹93.68000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Evommune, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Evommune, Inc. share’s latest price of $8.63 as on November 12, 2026 at 2:24 am IST, you will get 1.1587 shares of Evommune, Inc.. Learn more about fractional shares .